When are breast cancer patients old enough for the quitclaim of local control?

Strahlentherapie und Onkologie

Volumn 188, Issue 12, 2012, Pages 1069-1073

  Sautter Bihl, M L ^a   Sedlmayer, F ^b   Budach, W ^c   Dunst, J ^d   Feyer, P ^e   Fietkau, R ^f   Haase, W ^g   Harms, W ^h   Rodel C ⁱ   Souchon, R ^j   Wenz, F ^k   Sauer, R ^f  

^a STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e VIVANTES KLINIKUM NEUKÖLLN   (Germany)

^f UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^g formerly St Vincentius Kliniken   (Germany)

^h St Claraspital AG   (Switzerland)

ⁱ UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^j UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^k UNIVERSITY OF HEIDELBERG   (Germany)

more..

Author keywords

Breast cancer; European Society of Breast Cancer Specialists guidelines; Life expectancy; Older patients; Radiotherapy

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; ESTROGEN RECEPTOR; TAMOXIFEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ARTHRALGIA; BREAST CANCER; CANCER HORMONE THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL PRACTICE; COGNITION; COST EFFECTIVENESS ANALYSIS; DISEASE FREE SURVIVAL; DRUG SAFETY; DRUG WITHDRAWAL; ENDOMETRIUM CANCER; GERIATRIC ASSESSMENT; HEALTH CARE COST; HUMAN; LIFE EXPECTANCY; OSTEOLYSIS; OVERALL SURVIVAL; PARTIAL MASTECTOMY; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIDE EFFECT; THROMBOEMBOLISM; TREATMENT OUTCOME; ADJUVANT THERAPY; AGE; AGED; BREAST TUMOR; FEMALE; MORTALITY; MULTIMODALITY CANCER THERAPY; RISK FACTOR; SEGMENTAL MASTECTOMY; TUMOR RECURRENCE;

AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; NEOPLASM RECURRENCE, LOCAL; PRACTICE GUIDELINES AS TOPIC; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TREATMENT OUTCOME;

EID: 84872836089     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-012-0253-6     Document Type: Review

References (42)

1. AGO (2012) Diagnostik und Therapie primärer und metastasierter Mammakarzinome - Adjuvante Strahlentherapie. http://www.ago-online.de
2. Albert JM, Liu DD, Shen Y et al (2012) Nomogram to predict the benefit of, radiation for older patients with breast cancer treated with conservative surgery. J Clin Oncol 30:2837-2843
3. Balducci L (2003) Geriatric oncology. Crit Rev Oncol Hematol 46:211-220
4. Biganzoli L, Wildiers H, Oakman C et al (2012) Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol 13(4):e148-e160
5. Bouchardy C, Rapiti E, Fioretta G (2003) Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol 21:3580-3587
6. Burstein HJ (2007) Aromatase inhibitor-associated arthralgia syndrome. Breast 16(3):223-234
7. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373-383
8. Darby S, McGale P, Correa C et al (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomized trials. Lancet 378:1707-1716
9. Demissie S, Silliman RA, Lash TL (2001) Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women. J Clin Oncol 19(2):322
10. Deutsch M (2002) Radiotherapy after lumpectomy for breast cancer in very old women. Am J Clin Oncol 25:48-49
11. Extermann M, Aapro M, Bernabei R et al (2005) Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 55:241-252
12. Fyles AW, McCready DR, Manchul LA et al (2004) Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 351:963-970
13. Giordano SH (2012) Radiotherapy in older women with low-risk breast cancer: why did practice not change? J Clin Oncol 30(14):1577-1578
14. Giordano FA, Wenz F (2012) Nachteile für ältere Patientinnen mit Mammakarzinom durch Untertherapie. Strahlenther Onkol 188:527-528
15. Greenup RA, Camp MS, Taghian AG et al (2012) Comparison of radiation treatment options after lumpectomy for breast cancer. Ann Surg Oncol (Epub ahead of print)
16. Hancke K, Denkinger MD, König J et al (2010) Standard treatment of female patients with breast cancer decreases substantially for women aged 70 years and older: a German clinical cohort study. Ann Oncol 21:748-753
17. Hughes KS, Schnaper LA, Berry D et al (2004) Lumpectomy plus tamoxifen with or without irradiation in women age 70 or older with early breast cancer. N Engl J Med 351:971-977
18. Hughes KS, Schnaper LA, Cirrincione C et al (2010) Lumpectomy plus tamoxifen with or without irradiation in women age 70 or older with early breast cancer. J Clin Oncol 28:69 s (suppl 15, abstr 507)
19. Jahrbuch Statistisches Bundesamt für die Bundesrepublik Deutschland 2008: http://www.destatis.de
20. Jenkins PL, May VE, Hughes LE (1991) Psychological morbidity associated with local recur-rence of breast cancer. Int J Psychiatry Med 21:149-155
21. Klusmann V, Evers A, Schwarzer R et al (2010) Complex mental and physical activity in older women and cognitive performance: a 6-month randomized controlled trial. J Gerontol A Biol Sci Med Sci 65(6):680-688
22. Leitlinienprogramm Onkologie DKG, Deutsche Krebshilfe, AWMF (2012) Interdisziplinäre S3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms. http://www.senologie.org/fileadmin/downloads/S3- Brustkrebs-v2012-OL-Langversion.pdf
23. Muss HB, Tu D, Ingle JN (2008) Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17. J Clin Oncol 26(12):1956-1964
24. National Comprehensive Cancer Network (2012) NCCN Clinical Practice Guidelines in Oncology: Breast Cancer, Version 2.2012. http://www.nccn.org/ professionals/physician-gls/f-guidelines.asp#site
25. Owusu C, Buist DS, Field TS et al (2008) Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer. J Clin Oncol 26:549-555
26. Pötter R, Gnant M, Kwasny W (2007) Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer. Int J Radiat Oncol Biol Phys 68(2):334-340
27. Robert Koch Institut (2012) Krebs in Deutschland 2007-2008. Häufigkeiten und Trends, 8. überarbeitete Aufl. In: Robert-Koch-Institut, die Gesellschaft für epidemiologische Krebsregister in Deutschland e.V. (Hrsg) Robert Koch Institut, Berlin
28. Sautter-Bihl ML, Sedlmayer F, Budach W et al (2010) Intraoperative radiotherapy as accelerated partial breast irradiation for early breast cancer: beware of one-stop shops? Strahlenther Onkol 86(12):651-657
29. Sautter-Bihl ML, Souchon R, Gerber B (2011) Adjuvant therapy for women over age 65 with breast cancer. Dtsch Arztebl. Int 108 (21):365-371
30. Smith BD, Jiang J, McLaughlin SS et al (2011) Improvement in breast cancer outcomes over time: are older women missing out? J Clin Oncol 29(35):4647-4653
31. Soulos PR, Yu JB, Roberts KB et al (2012) Assessing the impact of a cooperative group trial on breast cancer care in the Medicare population. J Clin Oncol 30(14)1601-1607
32. START Trialists' Group, Bentzen SM, Agrawal RK, Aird EG et al (2008).The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 9:331-341
33. START Trialists' Group, Bentzen SM, Agrawal RK, Aird EG et al (2008).The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 371(9618):1098-1107
34. Truong PT, Bernstein V, Lesperance M et al (2006) Radiotherapy omission after breast-conserving surgery is associated with reduced breast cancer-specific survival in elderly women with breast cancer. Am J Surg 191:749-755
35. Vitetta L, Anton B (2007) Lifestyle and nutrition, caloric restriction, mitochondrial health and hormones: scientific interventions for anti-aging. Clin Interv Aging 2(4):537-543
36. Wazer DE (2012) Measuring the value of radiotherapy in older women with breast cancer. J Clin Oncol 30(23):2809-2811
37. WhelanTJ, Pignol JP, Levine MN (2010) Long term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 362:513-520
38. Williams LJ, Kunkler IH, King CC (2011) A randomised controlled trial of post-operative radiotherapy following breast-conserving surgery in a minimum-risk population. Quality of life at 5 years in the PRIME trial. Health Technol Assess. (12):i-xi, 1-57
39. Winzer KJ, Gruber C, Badakhshi H (2012)Compliance of patients concerning recommended radiotherapy in breast cancer: Association with recurrence, age, and hormonal therapy. Strahlenther Onkol 188(9):788-794
40. Wong J, D'Alimonte L, Angus J et al (2012) Development of patients' decision aid for older women with stage I breast cancer considering radiotherapy after lumpectomy. Int J Radiat Oncol Biol Phys 84(1):30-38
41. Yood Y MU, Owusu C, Buist DS et al (2008) Mortality impact of less-than-standard therapy in older breast cancer patients. J Am Coll Surg 206:66-75
42. Ziller V, Kalder M, Albert US et al (2009) Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer. Ann Oncol.3:431-436